HUTCHMED (China) Limited revenue breakdown overview

HUTCHMED (China) Limited revenue for the last year amounted to 838.00 M USD, the most of which — 364.45 M USD — came from its highest performing source at the moment, Oncology/Immunology - Research and Development, the year earlier bringing 39.20 M USD. The greatest contribution to the revenue figure was made by China — last year it brought HUTCHMED (China) Limited 484.89 M USD, and the year before that — 426.41 M USD.